Zakai H A, Zimmo S K
Medical Technology Program, Faculty of Medicine & Allied Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Ann Trop Med Parasitol. 2000 Dec;94(8):787-91. doi: 10.1080/00034980020027979.
The effects of two antifungal compounds, the azole itraconazole and the allylamine terbinafine, on Leishmania major infections in mice are reported. Sixty BALB/c mice were each inoculated subcutaneously with metacyclic promastigotes of L. major at the base of the tail. From 4 weeks post-inoculation, 40 of the mice were treated for 4 weeks (20 with itraconazole and 20 with terbinafine) and the rest were left untreated. Lesion sizes were estimated weekly for 10 weeks post-infection. Both drugs appeared effective in treating the cutaneous lesions but response to itraconazole was faster and, at the end of the experiment, the mean size of the lesions on the mice treated with itraconazole was smaller than that of the lesions on the terbinafine-treated mice.
报道了两种抗真菌化合物,即唑类的伊曲康唑和烯丙胺类的特比萘芬对小鼠利什曼原虫主要感染的影响。60只BALB/c小鼠在尾根部皮下接种利什曼原虫主要种的循环前鞭毛体。接种后4周起,40只小鼠接受为期4周的治疗(20只用伊曲康唑,20只用特比萘芬),其余小鼠不治疗。感染后10周每周估计病变大小。两种药物在治疗皮肤病变方面似乎都有效,但对伊曲康唑的反应更快,并且在实验结束时,用伊曲康唑治疗的小鼠的病变平均大小小于用特比萘芬治疗的小鼠的病变大小。